|
1. FDA to remove boxed warnings from hormone therapy for menopause Full story
2. Fresenius Kabi recalls 3 lots of GI drug Full story
3. Health systems are unbundling pharmacy benefits. See how they're regaining control here.
4. Inside Providence's plan for 340B rebate disruption Full story
5. Mark Cuban Cost Plus Drugs adds Stelara biosimilar Full story
6. 340B shift coming in 2026. Are you prepared to manage the rebate delay? Start here.
7. VCU Health to expand free pharmacy delivery services Full story
8. Cigna subsidiary's generics priced above market averages, report finds Full story
9. 2026 flu shot could be weaker than normal: 3 notes Full story
10. Industry leaders outline 4 strategies to bolster drug supply chain Full story
11. FAH president: After access gains, healthcare 'moving in the opposite direction' Full story
12. New host response tests are reshaping ED infection care. See how — here.
Becker's Learning Opportunities
13. From ICU to outpatient, see how hospitals close critical wireless gaps — here.
14. Buyout in sight? Make sure your ASC is deal-ready — compliance + valuation tips here.
15. More cases, same footprint: WakeMed's 21% boost in prime-time procedural case minutes, here.
16. Becker’s resources don’t stop here — explore more
webinars
and
whitepapers.
|
